Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on September 10, 2026

18 hours ago

ORYZON to Participate in Upcoming Events in September and October

Indeterminate GlobeNewswire

18 hours ago

Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases

Indeterminate GlobeNewswire

18 hours ago

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Indeterminate GlobeNewswire

18 hours ago

Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

Indeterminate GlobeNewswire

18 hours ago

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

18 hours ago

Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

18 hours ago

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Indeterminate GlobeNewswire

18 hours ago

SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer

Indeterminate GlobeNewswire

18 hours ago

IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

18 hours ago

Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire

18 hours ago

electroCore to Participate at H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

18 hours ago

Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting

Indeterminate GlobeNewswire

18 hours ago

Senseonics To Participate in Upcoming Institutional Investor Conferences

Indeterminate GlobeNewswire

18 hours ago

Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy

Indeterminate GlobeNewswire

Sep. 10, 2026

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

Indeterminate GlobeNewswire

Sep. 10, 2026

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

Indeterminate GlobeNewswire

Sep. 10, 2026

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Indeterminate GlobeNewswire

Sep. 10, 2026

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose

Indeterminate GlobeNewswire

Sep. 10, 2026

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Indeterminate GlobeNewswire

Sep. 10, 2026

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Indeterminate GlobeNewswire